Seppo Pyrhönen - UTU Research Portal

Seppo Pyrhönen

Clinical Oncology (Department of Clinical Medicine)

seppyr@utu.fi

Publications

1 of 3

Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study (2023)
- Anticancer Research
Kankuri-Tammilehto Minna, Perasto Laura, Pyrhönen Seppo, Salminen Eeva
(A1 Refereed original research article in a scientific journal)
Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer (2019)
- Anticancer Research
Bendardaf R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, Pyrhonen S
(A1 Refereed original research article in a scientific journal)
Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha (2018)
- Anticancer Research
Kalle Mattila, Pirita Raanta, Valtteri Lahtela, Seppo Pyrhonen, Ilkka Koskivuo, Pia Vihinen
(A1 Refereed original research article in a scientific journal)
Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen (2018)
- Anticancer Research
Riyad Bendardaf, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif-Askari, Kari Syrjänen, Seppo Pyrhönen
(A1 Refereed original research article in a scientific journal)
Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer (2017)
- Supportive Care in Cancer
Korkeila EA, Salminen T, Kallio R, Mikkola M, Auvinen P, Pyrhönen S, Ristamäki R
(A1 Refereed original research article in a scientific journal)
The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients (2017)
- Libyan Journal of Medicine
Bendardaf R, El-Serafi A, Syrjänen K, Colland Y, Pyrhönen S
(A1 Refereed original research article in a scientific journal)
Benefit of adjuvant interferon alfa-2b (IFN-alpha) therapy in melanoma patients with high serum MMP-8 levels (2015)
- Cancer Immunology, Immunotherapy
Vihinen P, Tervahartiala T, Sorsa T, Hansson J, Bastholt L, Aamdal S, Stierner U, Pyrhonen S, Syrjanen K, Lundin J, Hernberg M
(A1 Refereed original research article in a scientific journal)
e-Tietopalaute – näyttöä rintasyöpäpotilaan voimavaraistumista tukevasta ohjauksesta (2015)
- BestPractice Onkologia ja hematologia
Siekkinen M, Leino-Kilpi H, Pyrhönen S
(Other publication)
Psychosocial outcomes of e-feedback of radiotherapy for breast cancer patients: A randomized controlled trial (2015)
- Psycho-Oncology
Siekkinen M., Pyrhönen S., Ryhänen A., Vahlberg T., Leino-Kilpi H.
(A1 Refereed original research article in a scientific journal)
Randomized, controlled trial of the effect of e-feedback on knowledge about radiotherapy of breast cancer patients in Finland (2015)
- Nursing and Health Sciences
Mervi Siekkinen, Jukka Kesänen, Tero Vahlberg, Seppo Pyrhönen, Helena Leino-Kilpi
(A1 Refereed original research article in a scientific journal)
Toremifene in the treatment of breast cancer (2014)
- World Journal of Clinical Oncology
Mika VJ Mustonen, Seppo Pyrhönen, Pirkko-Liisa Kellokumpu-Lehtinen
(A1 Refereed original research article in a scientific journal)
ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer (2013)
- Human Pathology
Avoranta ST, Korkeila EA, Ristamäki RH, Syrjänen KJ, Carpén OM, Pyrhönen SO, Sundström JT
(A1 Refereed original research article in a scientific journal)
High Cyclooxygenase-2 Expression Is Associated with Advanced Stages in Colorectal Cancer (2013)
- Anticancer Research
Elzagheid A, Emaetig F, Alkikhia L, Buhmeida A, Syrjanen K, El-Faitori O, Laato M, Collan Y, Pyrhonen S
(A1 Refereed original research article in a scientific journal)
Ihosyöpä (2013) Syöpätaudit Suominen Erkki, Vihinen Pia, Pyrhönen Seppo
(D2 Article in a professional compilation book)
Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma (2013)
- Tumor Biology
Elzagheid A, Emaetig F, Buhmeida A, Laato M, El-Faitori O, Syrjänen K, Collan Y, Pyrhönen S
(A1 Refereed original research article in a scientific journal)
Prognostic value of bcl-2 expression among women with breast cancer in Libya (2013)
- Tumor Biology
Eramah Ermiah, Abdelbaset Buhmeida, Ben Romdhane Khaled, Fathi Abdalla, Nada Salem, Seppo Pyrhönen, Yrjö Collan
(A1 Refereed original research article in a scientific journal)
Diagnosis delay in Libyan female breast cancer (2012)
- BMC Research Notes
Eramah Ermiah, Fathi Abdalla, Abdelbaset Buhmeida, Entesar Larbesh, Seppo Pyrhönen, Yrjö Collan
(A1 Refereed original research article in a scientific journal)
Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence (2012)
- World Journal of Gastroenterology
Suvi Tuulia Avoranta, Eija Annika Korkeila, Kari Juhani Syrjänen, Seppo Olavi Pyrhönen, Jari Toivo Tapio Sundström
(A1 Refereed original research article in a scientific journal)
Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma (2012)
- APMIS
Elzagheid A, Buhmeida A, Laato M, El-Faitori O, Syrjanen K, Collan Y, Pyrhonen S
(A1 Refereed original research article in a scientific journal)
Main effects and interactions of carbonic anhydrase IX, hypoxiainducible factor-1a, ezrin and glucose transporter-1 multivariate analysis for disease outcome in rectal cancer. (2012)
- Anticancer Research
Pyrhönen Seppo, Korkeila Eija, Sundtrm Jari, Syrjänen Kari
(A1 Refereed original research article in a scientific journal)